Overview

Etanercept in New Onset Type 1 Diabetes

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

Summary

The investigators hypothesized that the administration of Etanercept to children newly diagnosed with T1DM may be able to interdict the progression of T1DM. The aim of this study is to evaluate the feasibility and safety of Etanercept administration to pediatric patients recently diagnosed with type 1 DM.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

University at Buffalo

Collaborator:

Amgen

Treatments:

Etanercept